WallStreetZenWallStreetZen

NASDAQ: ALBO
Albireo Pharma Inc Stock

Open Broker Account
$19.36+0.63 (+3.36%)
Updated Sep 30, 2022
ALBO Price
$19.36
Fair Value Price
$28.60
Market Cap
$379.70M
52 Week Low
$16.02
52 Week High
$37.63
P/E
-10.52x
P/B
3.34x
P/S
7.59x
PEG
N/A
Dividend Yield
N/A
Revenue
$51.22M
Earnings
-$36.26M
Gross Margin
95.4%
Operating Margin
-46.95%
Profit Margin
-70.8%
Debt to Equity
1.02
Operating Cash Flow
-$113M
Beta
1.14
Next Earnings
Nov 2, 2022
Ex-Dividend
N/A
Next Dividend
N/A

ALBO Overview

Zen Score

Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ALBO scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ALBO ($19.36) is undervalued by 32.31% relative to our estimate of its Fair Value price of $28.60 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
ALBO ($19.36) is significantly undervalued by 32.31% relative to our estimate of its Fair Value price of $28.60 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
ALBO is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more ALBO due diligence checks available for Premium users.

Be the first to know about important ALBO news, forecast changes, insider trades & much more!

ALBO News

Valuation

ALBO fair value

Fair Value of ALBO stock based on Discounted Cash Flow (DCF)
Price
$19.36
Fair Value
$28.60
Undervalued by
32.31%
ALBO ($19.36) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ALBO ($19.36) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ALBO is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

ALBO price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-10.52x
Industry
14.28x
Market
27.64x

ALBO price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
3.34x
Industry
4.39x
ALBO is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ALBO's financial health

Profit margin

Revenue
$8.2M
Net Income
-$39.9M
Profit Margin
-486.8%
ALBO's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
ALBO's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$229.0M
Liabilities
$115.3M
Debt to equity
1.02
ALBO's short-term assets ($195.75M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ALBO's short-term assets ($195.75M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ALBO's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
ALBO's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$36.4M
Investing
-$685.0k
Financing
$1.8M
ALBO's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ALBO vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
ALBO$379.70M+3.36%-10.52x3.34x
CNTA$379.24M-5.41%-1.82x0.90x
IMRX$377.94M+9.15%-9.88x2.83x
GLUE$381.65M+4.21%-5.04x1.26x
QSI$383.27M+0.73%-3.87x0.93x

Albireo Pharma Stock FAQ

What is Albireo Pharma's quote symbol?

NASDAQ: ALBO) Albireo Pharma trades on the NASDAQ under the ticker symbol ALBO. Albireo Pharma stock quotes can also be displayed as NASDAQ: ALBO.

If you're new to stock investing, here's how to buy Albireo Pharma stock.

What is the 52 week high and low for Albireo Pharma (NASDAQ: ALBO)?

(NASDAQ: ALBO) Albireo Pharma's 52-week high was $37.63, and its 52-week low was $16.02. It is currently -48.55% from its 52-week high and 20.85% from its 52-week low.

How much is Albireo Pharma stock worth today?

(NASDAQ: ALBO) Albireo Pharma currently has 19,612,509 outstanding shares. With Albireo Pharma stock trading at $19.36 per share, the total value of Albireo Pharma stock (market capitalization) is $379.70M.

Albireo Pharma stock was originally listed at a price of $2,160.00 in May 11, 2007. If you had invested in Albireo Pharma stock at $2,160.00, your return over the last 15 years would have been -99.1%, for an annualized return of -26.97% (not including any dividends or dividend reinvestments).

How much is Albireo Pharma's stock price per share?

(NASDAQ: ALBO) Albireo Pharma stock price per share is $19.36 today (as of Sep 30, 2022).

What is Albireo Pharma's Market Cap?

(NASDAQ: ALBO) Albireo Pharma's market cap is $379.70M, as of Oct 2, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Albireo Pharma's market cap is calculated by multiplying ALBO's current stock price of $19.36 by ALBO's total outstanding shares of 19,612,509.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.